Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

SELUTION 4 De Novo Small Vessel IDE Trial

ClinicalTrials.gov ID: NCT05946629

Public ClinicalTrials.gov record NCT05946629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-market approval (PMA) application to the United States (US) FDA. The Study will enroll up to 910 randomized subjects, up to 30 subjects in a parallel angiographic substudy, and up to 20 subjects in a parallel pharmacokinetic (pK) substudy, at up to 80 sites in the US, Canada, Brazil, Japan and Europe. A minimum of 50% of the subjects will be enrolled in the US.

Study identification

NCT ID
NCT05946629
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
M.A. Med Alliance S.A.
Industry
Enrollment
960 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 20, 2023 (Actual)
Primary completion
Sep 2027 (Estimated)
Completion
Sep 2031 (Estimated)
Last update posted
Sep 24, 2026

2023 – 2031

United States locations

U.S. sites
65
U.S. states
32
U.S. cities
57
Facility City State ZIP Site status
St. Bernards Jonesboro Arkansas 72401 —
CISD Sharp Chula Vista Chula Vista California 91911 —
Cedars Sinai Los Angeles California 90048 —
HCA Los Robles Thousand Oaks California 91360 —
Harbor UCLA Torrance California 90502 —
Colorado Heart and Vascular Golden Colorado 80401 —
ClinRe Thornton Colorado 80023 —
Yale New Haven Hospital New Haven Connecticut 06520 —
MedStar Washington Hospital Center Washington D.C. District of Columbia 20010 —
Manatee Memorial Bradenton Florida 34208 —
Mease Countryside Hospital Clearwater Florida 34695 —
University of Florida, Jacksonville Jacksonville Florida 32209 —
HCA Largo Largo Florida 33770 —
AdventHealth Orlando Orlando Florida 32803 —
HCA Northside St. Petersburg Florida 33709 —
HCA Trinity Trinity Florida 34655 —
Atlanta VA Atlanta Georgia 30033 —
Piedmont Heart Institute Atlanta Georgia 30309 —
Emory Atlanta Georgia 30322 —
Hamilton Medical Center Dalton Georgia 30720 —
Archbold Memorial Hospital Thomasville Georgia 31792 —
Pali Momi Medical Center ‘Aiea Hawaii 96701 —
Advocate Good Samaritan Hospital Downers Grove Illinois 60515 —
Advocate Christ Medical Center Oak Lawn Illinois 60453 —
Carle Foundation Hospital Urbana Illinois 61801 —
University of Iowa Medical Center Iowa City Iowa 52242 —
Cardiovascular Research Institute of Kansas Wichita Kansas 67226 —
Baptist Health Lexington Lexington Kentucky 40503 —
Cardiovascular Institute of the South Houma Louisiana 70360 —
University of Maryland Baltimore Maryland 21201 —
Beth Israel Deaconess Boston Massachusetts 02114 —
Mass General Boston Massachusetts 02114 —
Brigham & Women's Boston Massachusetts 02115 —
Baystate Medical Center Springfield Massachusetts 01199 —
Minneapolis Heart Institute Minneapolis Minnesota 55407 —
Minneapolis VA Medical Center Minneapolis Minnesota 55417 —
North Mississippi Medical Center Tupelo Mississippi 38801 —
HCA Overland Park Overland Park Missouri 66211 —
St. Louis Heart and Vascular St Louis Missouri 63136 —
University of Nebraska Omaha Nebraska 68198 —
Englewood Health Englewood New Jersey 07631 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Northwell Health Lenox Hill New York New York 10075 —
Stony Brook University Hospital Stony Brook New York 11794 —
NC Heart and Vascular Raleigh North Carolina 27607 —
The Lindner Research Center at Christ Cincinnati Ohio 45219 —
UH Cleveland Cleveland Ohio 44120 —
Oklahoma Heart Oklahoma City Oklahoma 73120 —
Penn State Health Hershey & Berks Hershey Pennsylvania 17033 —
UPMC Pinnacle Mechanicsburg Pennsylvania 17050 —
WellSpan York Hospital York Pennsylvania 17403 —
Lifespan Rhode Island & Miriam Providence Rhode Island 02903 —
CHI Memorial Chattanooga Tennessee 37404 —
University of Nebraska Chattanooga Tennessee 37404 —
HCA Centennial Nashville Tennessee 37203 —
Hendrick Health Abilene Texas 79601 —
Texas Health Dallas Texas 75231 —
Baylor Scott and White - Dallas Dallas Texas 75246 —
Medical City of Fort Worth Fort Worth Texas 76104 —
Baylor Scott and White Plano Plano Texas 75093 —
Baylor Scott and White - Temple Temple Texas 76508 —
Intermountain Health - Salt Lake City Murray Utah 84107 —
HCA Chippenham Richmond Virginia 23225 —
CAMC Charleston West Virginia 25304 —
Advocate Aurora St. Luke's Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05946629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05946629 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →